This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Layfield LJ , Roy-Chowdhuri S , Baloch Z , Ehya H , Geisinger K , Hsiao SJ , Lin O , Lindeman NI , Roh M , Schmitt F , Sidiropoulos N , VanderLaan PA
Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology
Diagn Cytopathol. 2016 Dec;44(12) :1000-1009
PMID: 27561242 PMCID: PMC5590370 URL: https://www.ncbi.nlm.nih.gov/pubmed/27561242
AbstractThe Papanicolaou Society of Cytopathology has developed a set of guidelines for respiratory cytology including indications for sputum examination, bronchial washings and brushings, CT-guided FNA and endobronchial ultrasound guided fine needle aspiration (EBUS-FNA), as well as recommendations for classification and criteria, ancillary testing and post-cytologic diagnosis management and follow-up. All recommendation documents are based on the expertise of committee members, an extensive literature review, and feedback from presentations at national and international conferences. The guideline documents selectively present the results of these discussions. The present document summarizes recommendations for ancillary testing of cytologic samples. Ancillary testing including microbiologic, immunocytochemical, flow cytometric, and molecular testing, including next-generation sequencing are discussed. Diagn. Cytopathol. 2016;44:1000-1009. (c) 2016 Wiley Periodicals, Inc.
NotesLayfield, Lester J Roy-Chowdhuri, Sinchita Baloch, Zubair Ehya, Hormoz Geisinger, Kim Hsiao, Susan J Lin, Oscar Lindeman, Neal I Roh, Michael Schmitt, Fernando Sidiropoulos, Nikoletta VanderLaan, Paul A ENG 2016/08/27 06:00 Diagn Cytopathol. 2016 Dec;44(12):1000-1009. doi: 10.1002/dc.23549. Epub 2016 Aug 26.